About ADMS

Adamas Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on those affected by chronic disorders of the central nervous system. The company achieves this by modifying the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone or in fixed-dose combination products. Adamas is currently developing its lead wholly-owned product candidate, ADS-5102, for a complication associated with the treatment of Parkinson's disease known as levodopa-induced dyskinesia, or LID, and is evaluating other potential indications. The company's portfolio also includes two approved products with Forest Laboratories Holdings Limited (a subsidiary of Actavis plc), Namzaric(TM) and Namenda XR(R). Forest is responsible for marketing both products in the United States under an exclusive license from Adamas. For more information, please visit www.adamaspharma.com.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADMS is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.40497E+09 1,988 1988 0.0% 2.5E-05 34 K 34088
IBB iShares Nasdaq Biotechnology Index Fund 7.3 B 7.34933E+09 222 222 0.02% 0.0002 1.5 M 1496950
ITOT iShares Core S&P Total U.S. Stock Market ETF 19.5 B 1.95299E+10 3,547 3547 0.0% 0 126 K 125832
IWC iShares Microcap ETF 847.3 M 8.47282E+08 1,434 1434 0.03% 0.0003 273 K 272580
IWM iShares Russell 2000 ETF 40.5 B 4.05202E+10 1,989 1989 0.01% 0.0001 2.3 M 2329050
IWN iShares Russell 2000 Value ETF 8.6 B 8.58367E+09 1,355 1355 0.01% 0.0001 504 K 503575
IWO iShares Russell 2000 Growth ETF 8.8 B 8.79796E+09 1,232 1232 0.01% 0.0001 499 K 499238
IWV iShares Russell 3000 ETF 9.1 B 9.10141E+09 2,929 2929 0.0% 0 35 K 34939
FHLC Fidelity MSCI Health Care Index ETF 1.5 B 1.5E+09 356 356 0.0% 2.8633E-05 43 K 43496
BIB ProShares Ultra Nasdaq Biotechnology 223.8 M 2.2382E+08 239 239 0.01% 8.41484E-05 39 K 39440
UBIO Proshares UltraPro Nasdaq Biotechnology 28.3 M 2.82606E+07 228 228 0.01% 5.55811E-05 5 K 4888
URTY ProShares UltraPro Russell2000 85.2 M 8.5176E+07 2,005 2005 0.0% 1.44612E-05 4 K 3949
UWM ProShares Ultra Russell2000 181.5 M 1.8146E+08 2,006 2006 0.0% 1.98489E-05 8 K 8060